Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma

Tissue factor (TF) is a transmembrane glycoprotein to initiate blood coagulation and frequently overexpressed in a variety of tumors. Our previous study has showed that the expression of TF is upregulated and correlated with prognosis in hepatocellular carcinoma (HCC). However, the role and molecula...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Huang, Shan-Zhou, Wei, Meng-Ning, Huang, Jia-Rong, Zhang, Zi-Jian, Zhang, Wen-Ji, Jiang, Qi-Wei, Yang, Yang, Wang, Huan-Yu, Jin, Hui-Lin, Wang, Kun, Xing, Zi-Hao, Yuan, Meng-Ling, Li, Yao, He, Xiao-Shun, Shi, Zhi, Zhou, Qi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2019
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6428933/
https://ncbi.nlm.nih.gov/pubmed/30931258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00150
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia